Tian Y - Search Results

1

[Progress of platelet derived grow factor family in non-small cell lung cancer].

Tian Y, Chu Q, Chen Y. Tian Y, et al. Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):42-8. doi: 10.3779/j.issn.1009-3419.2014.01.07. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24398313 Free PMC article. Review. Chinese.

2

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer.

Sun W, Yuan X, Tian Y, Wu H, Xu H, Hu G, Wu K. Sun W, et al. Among authors: tian y. J Hematol Oncol. 2015 Jul 31;8:95. doi: 10.1186/s13045-015-0193-6. J Hematol Oncol. 2015. PMID: 26227959 Free PMC article. Review.

3

Emerging roles of Nrf2 signal in non-small cell lung cancer.

Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q, Wu K. Tian Y, et al. J Hematol Oncol. 2016 Feb 27;9:14. doi: 10.1186/s13045-016-0246-5. J Hematol Oncol. 2016. PMID: 26922479 Free PMC article. Review.

4

The CXCL8-CXCR1/2 pathways in cancer.

Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T, Chen Y, Han X, Wu K. Liu Q, et al. Among authors: tian y. Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25. Cytokine Growth Factor Rev. 2016. PMID: 27578214 Free PMC article. Review.

5

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.

Tian Y, Wu K, Liu Q, Han N, Zhang L, Chu Q, Chen Y. Tian Y, et al. J Hematol Oncol. 2016 Sep 6;9(1):83. doi: 10.1186/s13045-016-0311-0. J Hematol Oncol. 2016. PMID: 27601007 Free PMC article.

6

The expression profile and clinic significance of the SIX family in non-small cell lung cancer.

Liu Q, Li A, Tian Y, Liu Y, Li T, Zhang C, Wu JD, Han X, Wu K. Liu Q, et al. Among authors: tian y. J Hematol Oncol. 2016 Nov 8;9(1):119. doi: 10.1186/s13045-016-0339-1. J Hematol Oncol. 2016. PMID: 27821176 Free PMC article. Review.

7

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers.

Tian Y, Liu Q, Wu K, Chu Q, Chen Y, Wu K. Tian Y, et al. Oncotarget. 2017 Apr 28;8(37):62330-62338. doi: 10.18632/oncotarget.17499. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977948 Free PMC article.

8

The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin.

Li J, Peng P, Mei Q, Xia S, Tian Y, Hu L, Chen Y. Li J, et al. Among authors: tian y. Support Care Cancer. 2018 Aug;26(8):2763-2767. doi: 10.1007/s00520-018-4130-4. Epub 2018 Mar 3. Support Care Cancer. 2018. PMID: 29502154

9

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial-mesenchymal transition.

Chen Y, Li WW, Peng P, Zhao WH, Tian YJ, Huang Y, Xia S, Chen Y. Chen Y, et al. Among authors: tian yj. Acta Pharmacol Sin. 2019 Aug;40(8):1085-1094. doi: 10.1038/s41401-019-0215-y. Epub 2019 Feb 22. Acta Pharmacol Sin. 2019. PMID: 30796356 Free PMC article.

10

NRF2-Driven KEAP1 Transcription in Human Lung Cancer.

Tian Y, Liu Q, Yu S, Chu Q, Chen Y, Wu K, Wang L. Tian Y, et al. Mol Cancer Res. 2020 Oct;18(10):1465-1476. doi: 10.1158/1541-7786.MCR-20-0108. Epub 2020 Jun 22. Mol Cancer Res. 2020. PMID: 32571982 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,208 results

Search Page

Filters